Press Releases Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Market Closed - Nasdaq Stockholm Other stock markets 13:10:07 14/05/2024 BST			5-day change	1st Jan Change
32.4 ^SEK	0.00%		+1.25%	+28.57%

04-18	Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-22	Magle Chemoswed Holding AB Resolves to Withdraws Dividend Proposal for the Year 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MAGLE GROUP REPORTS OUTCOME AND EXTENDS THE ACCEPTANCE PERIOD FOR THE PUBLIC TENDER OFFER TO THE SHAREHOLDERS OF AMNIOTICS	05-07	AQ
Bulletin from Annual General Meeting in Magle Chemoswed Holding AB (publ) held on the 25th of April 2024	04-25	AQ
Magle Chemoswed Q1 - Expansion by acquisition	04-19	AQ
Magle Chemoswed Holding Reports Financial Results For First Quarter 2024	04-18	AQ
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB	04-05	AQ
Magle Chemoswed Holding AB (publ) Releases Annual Report for 2023.	03-26	AQ
NOTICE OF ANNUAL GENERAL MEETING IN MAGLE CHEMOSWED HOLDING AB (PUBL)	03-25	AQ
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total	03-22	AQ
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed	03-22	AQ
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB	03-22	AQ
Magle Chemoswed Q4 - Ramp up in sales	02-19	AQ
Magle Chemoswed Holding AB (PUBL) – Publishes Full Year Report 2023 and Board’s Initial Proposal for Paying Dividends	02-16	AQ
Magle Chemoswed Q3 2023 - DSM business advancements	26/10/23	AQ
Magle Chemoswed Holding Reports Financial Results For Third Quarter 2023	25/10/23	AQ
Magle Group enters collaboration with Sirtex Medical to support the international commercialization of EmboCept® S DSM 50 µm	08/09/23	AQ
Magle Chemoswed Q2 2023 - Progress toward transition	19/07/23	AQ
Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023	18/07/23	AQ
Magle Group initiates collaboration with leading German university hospital to explore synergies between EmboCept® S DSM 50 µm and immunotherapies	28/06/23	AQ
Magle Group applies for extended patent protection of its DSM technology in Europe	24/05/23	AQ
CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group	16/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Press Releases

Filters